U.S. Telecom Services and Carriers Stock News

NYSE:KRO
NYSE:KROChemicals

Kronos Worldwide (KRO) Q4 Loss Deepens To US$0.72 EPS And Tests Profit-Recovery Hopes

Kronos Worldwide (KRO) closed out FY 2025 with Q4 revenue of US$418.3 million and a basic EPS loss of US$0.72, capping off a trailing twelve month period where revenue totaled US$1.9 billion and basic EPS came in at a loss of US$0.96. Over recent quarters, the company has seen revenue move from US$423.1 million and basic EPS of a US$0.11 loss in Q4 2024 to US$489.8 million with EPS of US$0.16 in Q1 2025, before stepping down to US$456.9 million and a US$0.32 loss in Q3 2025 and ending at...
NYSE:SYK
NYSE:SYKMedical Equipment

Stryker SmartHospital Launch Puts Digital Growth And Valuation In Focus

Stryker (NYSE:SYK) has launched its new SmartHospital Platform, a digital solution for hospitals. The platform is designed to unify devices, data, and care teams across clinical settings. Key features include voice-activated communication, a workflow engine, virtual care support, and ambient intelligence tools. Stryker is widely known for its medical devices and equipment, and the SmartHospital Platform adds a broader digital layer on top of that hardware footprint. By focusing on workflow...
NasdaqGS:CECO
NasdaqGS:CECOMachinery

A Look At CECO Environmental (CECO) Valuation After Recent Share Price Weakness

Recent performance and context for CECO Environmental With no specific news event driving headlines today, CECO Environmental (CECO) still sits on investors’ radar after a mixed run, including a recent 25% decline over the past month and 6.8% decline over the past 3 months. See our latest analysis for CECO Environmental. Despite the recent 24.9% 1 month share price decline and 6.8% 3 month share price decline, CECO Environmental’s 1 year total shareholder return of 136.9% and very large 5...
NYSE:GME
NYSE:GMESpecialty Retail

GameStop (GME) Valuation Check After Mixed Short And Long Term Shareholder Returns

GameStop at a glance GameStop (GME) continues to draw attention from retail investors, with the share price at $24.37 and an implied intrinsic discount of 78.47% based on the provided valuation estimate. Recent returns show mixed momentum, with a 1 day decline of 1.73%, a 7 day gain of 2.31%, a 2.44% decline over the past month, and a 10.17% gain over the past 3 months. See our latest analysis for GameStop. For context, GameStop’s share price return has been positive year to date at 18.19%,...
NasdaqGM:SIGA
NasdaqGM:SIGAPharmaceuticals

SIGA Technologies (SIGA) Is Down 9.2% After Steep Q4 Profit Drop Despite New Asia Pacific Contract

SIGA Technologies, Inc. reported past fourth-quarter 2025 revenue of US$3.8 million versus US$81.4 million a year earlier, swinging from net income of US$45.7 million to a net loss of US$5.4 million. For 2025 as a whole, revenue fell to US$94.57 million and net income to US$23.28 million, even as SIGA secured a new US$13 million oral TPOXX procurement order in the Asia Pacific region in January 2026. We’ll now examine how the earnings decline alongside the new Asia Pacific TPOXX contract...
NasdaqGS:AMBA
NasdaqGS:AMBASemiconductor

Is There Now An Opportunity In Ambarella (AMBA) After Recent Share Price Weakness

If you are wondering whether Ambarella's current share price offers value or just more volatility, you are not alone and this article is here to help you weigh that up clearly. The stock last closed at US$54.00, with returns of a 4.5% decline over 7 days, a 17.2% decline over 30 days, a 28.2% decline year to date, a 3.8% gain over 1 year, a 29.5% decline over 3 years and a 51.2% decline over 5 years. Taken together, this gives you a mixed picture of short term pressure and longer term swings...
NYSE:LAZ
NYSE:LAZCapital Markets

Is Lazard (LAZ) Attractive After Recent Share Price Weakness And Valuation Gap?

If you are wondering whether Lazard's current share price still reflects its true worth, you are not alone. The stock has been attracting attention from investors asking exactly that question. Lazard closed at US$43.04, with recent returns of a 12.4% decline over 7 days, a 24.2% decline over 30 days, a 13.5% decline year to date and a 2.5% decline over 1 year. The 3 year and 5 year returns stand at 50.1% and 23.7% respectively. Recent news flow around Lazard has centered on its role as a...
NasdaqGS:MGNX
NasdaqGS:MGNXBiotechs

MacroGenics (MGNX) Loss Of US$74.6 Million Tests Bullish Loss‑Narrowing Narrative

MacroGenics (MGNX) has wrapped up FY 2025 with fourth quarter revenue of US$41.2 million and a basic EPS loss of US$0.22, as the market weighs these results against a share price of US$3.43. The company has seen revenue move from US$110.7 million in Q3 2024 to US$72.8 million in Q3 2025, while basic EPS shifted from a profit of US$0.90 to a profit of US$0.27 over the same period, creating a mixed picture on topline scale and per share results. Overall, margins remain under pressure, which...
NYSE:PWR
NYSE:PWRConstruction

Is It Too Late To Consider Quanta Services (PWR) After Its 1-Year 129.5% Surge?

If you are wondering whether Quanta Services at around US$564 per share still offers value after a huge run, you are not alone. This article is built to help you frame that question clearly. The stock has been volatile in the short term, with a 0.3% decline over the last 7 days, but the 1 month return of 11.0%, year to date return of 28.3%, 1 year return of 129.5% and a very large 5 year gain hint that the market has been steadily rethinking what this business is worth. Recent news coverage...
NYSE:NEU
NYSE:NEUChemicals

A Look At NewMarket (NEU) Valuation After Recent Share Price Weakness

NewMarket stock at a glance NewMarket (NEU) has caught investor attention after recent trading left the shares with a month return of about a 14% decline and a past 3 months return near a 19% decline. See our latest analysis for NewMarket. Despite the recent 30 day share price return of about a 14% decline and a 90 day share price return near a 19% decline, NewMarket’s 1 year total shareholder return of about 15% and multi year total shareholder returns above 70% indicate longer term holders...
NYSE:CHWY
NYSE:CHWYSpecialty Retail

Chewy (CHWY) Valuation Check As Margin Guidance Reaffirmation And Analyst Upgrade Highlight Growth Drivers

Chewy (CHWY) shares were in focus after the company reaffirmed its FY25 adjusted EBITDA margin guidance of 5.6% to 5.7%, and an upgrade from Raymond James highlighted its Autoship-driven revenues and pet health offerings. See our latest analysis for Chewy. Even with the reaffirmed margin guidance and recent analyst upgrade, Chewy’s 90 day share price return of 27.51% and 1 year total shareholder return of 22.77% indicate momentum has been under pressure. This suggests recent news is being...
NasdaqGS:TTAN
NasdaqGS:TTANSoftware

Is It Time To Reassess ServiceTitan (TTAN) After Its Recent Share Price Pullback?

This article is designed to help you think about whether ServiceTitan is starting to look like good value or remains priced for high expectations. The stock recently closed at US$77.90, with returns of 2.8% over 7 days and 22.2% over 30 days, while year to date it shows a 23.3% decline and a 1-year return of an 8.4% decline. Recent news coverage has focused on ServiceTitan as a key software provider for trades and home services companies, highlighting its role in helping contractors manage...
NasdaqCM:IRD
NasdaqCM:IRDBiotechs

Opus Genetics (IRD) Trailing US$49.6m Loss Reinforces Bearish Profitability Narrative

Opus Genetics (IRD) has reported FY 2025 results with Q4 revenue of US$3.9 million, a basic EPS loss of US$0.21, and a net income loss of US$16.5 million. The trailing twelve month figures show revenue of US$14.2 million, a basic EPS loss of US$0.80, and a net income loss of US$49.6 million. Over the recent quarters in FY 2025, the company has reported revenue between US$2.9 million and US$4.4 million, while quarterly basic EPS losses have ranged from US$0.12 to US$0.25 per share. These...
NYSE:AMPX
NYSE:AMPXElectrical

Why Amprius Technologies (AMPX) Is Up 54.8% After Issuing 2026 Guidance And ESOP Share Registration

Amprius Technologies, Inc. recently reported that 2025 sales rose to US$73.01 million with a net loss of US$44.02 million, issued 2026 guidance targeting at least US$125.0 million in revenue and a net loss under US$8.0 million (or US$0.06 per share), and filed a US$120.19 million shelf registration for 8,071,632 ESOP-related common shares. Together with new manufacturing partnerships to expand high-performance silicon battery production and upcoming conference appearances, these steps signal...
NYSE:DECK
NYSE:DECKLuxury

Assessing Deckers Outdoor (DECK) After Recent Share Price Weakness

If you are wondering whether Deckers Outdoor is still fairly priced or offering value after its recent share price swings, you are not alone. The stock last closed at US$105.26, with returns of a 4.2% decline over 7 days, an 8.8% decline over 30 days, a 1.4% decline year to date, a 12.7% decline over 1 year, and gains of 50.4% over 3 years and 86.5% over 5 years. These mixed returns have kept Deckers Outdoor on many investors' watchlists, as the share price performance over different time...
NYSE:LEVI
NYSE:LEVILuxury

Levi Strauss Dockers Sale Sharpens Focus On Denim And Direct Sales

Levi Strauss (NYSE:LEVI) has completed the sale of its Dockers brand to Authentic Brands Group. The transaction shifts Levi Strauss further toward its core denim business and direct to consumer model. The company plans to prioritize flagship segments such as denim and Beyond Yoga following the divestment. For investors, the key point is that Levi Strauss is sharpening its focus on areas it identifies as core to its identity, including denim and its Beyond Yoga brand. The Dockers sale...
NYSE:KFY
NYSE:KFYProfessional Services

Is Korn Ferry (KFY) Pricing Reflect Long Term Consulting Story After Recent Share Pullback

If you are wondering whether Korn Ferry's current share price reflects its underlying business, this article will walk through what the market might be pricing in and where gaps could exist. The stock last closed at US$62.59, with returns of 0.2% over 7 days, an 8.1% decline over 30 days, a 5.7% decline year to date, a 4.4% decline over 1 year, 26.4% over 3 years and 7.4% over 5 years. These moves may signal shifting views on its future potential and risk. Recent coverage of Korn Ferry has...
NYSE:KO
NYSE:KOBeverage

The Bull Case For Coca-Cola (KO) Could Change Following Its 64th Straight Dividend Hike And Guidance

In recent weeks, Coca-Cola reported steady 2025 organic revenue and earnings growth, reaffirmed guidance for 2026, and its board approved a 4% increase in the quarterly dividend, marking the company’s 64th consecutive annual dividend raise. These updates, alongside management’s emphasis on an asset-light model, improving free cash flow, and resilient global beverage demand, underscore Coca-Cola’s capacity to keep generating cash and returning it to shareholders even as consumer preferences...
NYSE:GWRE
NYSE:GWRESoftware

A Look At Guidewire Software (GWRE) Valuation After Recent Share Price Swings

Why Guidewire Software (GWRE) is on investors’ radar today Guidewire Software (GWRE) has drawn fresh attention after a recent share move, with the stock closing at $158.93. Investors are weighing this price against its current fundamentals and recent return profile. Over the past week, the stock shows a 4.6% gain, adding to a roughly 24% move over the past month, even as the past 3 months reflect about a 20.8% decline. That mixed pattern is prompting some investors to recheck whether the...
NYSE:EPRT
NYSE:EPRTREITs

Assessing Essential Properties Realty Trust (EPRT) Valuation After Recent Share Price Momentum

Why Essential Properties Realty Trust is on investors’ radar today Without a specific news headline driving Essential Properties Realty Trust (EPRT) today, many investors are looking at the stock’s recent performance, income profile, and fundamentals to decide whether it still fits their portfolio. See our latest analysis for Essential Properties Realty Trust. At a share price of US$33.71, Essential Properties Realty Trust has seen a 6.17% 1 month share price return and 9.41% 3 month share...
NasdaqGS:SNPS
NasdaqGS:SNPSSoftware

Is It Too Late To Consider Synopsys (SNPS) After Recent Share Price Strength?

If you are wondering whether Synopsys at around US$432.65 is still a sensible entry or hold after its recent run, you are not alone. Valuation is where that question really gets tested. The stock has returned 2.0% over the last week and 1.4% over the last month, while the year to date return sits at a 9.9% decline and the 1 year return is 0.5%, with longer term 3 year and 5 year returns of 17.0% and 84.9% respectively. Recent coverage around Synopsys has focused on its role in software and...
NasdaqGS:XMTR
NasdaqGS:XMTRTrade Distributors

A Look At Xometry (XMTR) Valuation After New AI Lead Time And Pricing Model Rollout

Xometry (XMTR) has rolled out a new Enterprise Machining Lead Time Prediction Model and updated pricing logic, expanding its Instant Quoting Engine and sharpening the AI tools that underpin its industrial sourcing marketplace. See our latest analysis for Xometry. Despite the recent product roll out and conference appearances, Xometry’s share price has come under pressure, with a 30 day share price return of a 37.54% decline and a 90 day share price return of a 32.67% decline, even as its 1...
NYSE:ALG
NYSE:ALGMachinery

Assessing Alamo Group (ALG) Valuation After Recent Share Price Weakness

Why Alamo Group Is On Investors’ Radar Alamo Group (ALG) shares have slipped about 18% over the past month, while the past 3 months show a small positive return. This has prompted some investors to reassess the equipment maker’s current valuation and fundamentals. See our latest analysis for Alamo Group. Looking beyond this month’s pullback, Alamo Group’s 30 day share price return of 18.37% and year to date share price return close to flat sit alongside a 1 year total shareholder return of...
NYSE:LLY
NYSE:LLYPharmaceuticals

Eli Lilly Expands Korea Gateway Labs As Valuation Signals Potential Upside

Eli Lilly (NYSE:LLY) has partnered with Samsung Biologics to establish a new Lilly Gateway Labs site in Korea. This marks the first international expansion of Lilly's Gateway Labs model, which supports early stage biotech companies. The Korea site is intended to attract biotech startups and deepen Lilly's presence in Asian life sciences ecosystems. Eli Lilly enters this move with a share price of $1,001.35 and a multi year return that is very large over the past 5 years. Over the last year,...